High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies | Zendy

Brian A. Raphael | Zendy; Daniel B. Shin | Zendy; Karen Rebecca Suchin | Zendy; Kelly A. Morrissey | Zendy; Carmela C. Vittorio | Zendy; Ellen J. Kim | Zendy; Jennifer M. Gardner | Zendy; Katherine G. Evans | Zendy; Camille E. Introcaso | Zendy; Sara Samimi | Zendy; Joel M. Gelfand | Zendy; Alain H. Rook | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies

Author(s) -

Brian A. Raphael,

Daniel B. Shin,

Karen Rebecca Suchin,

Kelly A. Morrissey,

Carmela C. Vittorio,

Ellen J. Kim,

Jennifer M. Gardner,

Katherine G. Evans,

Camille E. Introcaso,

Sara Samimi,

Joel M. Gelfand,

Alain H. Rook

Publication year - 2011

Publication title -

archives of dermatology

Language(s) - English

Resource type - Journals

eISSN - 1538-3652

pISSN - 0003-987X

DOI - 10.1001/archdermatol.2011.232

Subject(s) - medicine , photopheresis , cutaneous t cell lymphoma , complete response , cd8 , cohort , mycosis fungoides , extracorporeal photopheresis , gastroenterology , lymphoma , cancer , oncology , surgery , chemotherapy , immune system , disease , immunology , graft versus host disease

To quantify response rates of Sézary syndrome (SS) to multimodality immunomodulatory therapy and to identify the important prognostic parameters that affect overall response to treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research